EntityWire

EntityWire / EIN 26-3407249

SEC filer

Inhibikase Therapeutics, Inc.

EIN 26-3407249. What Florida Division of Corporations (Sunbiz) bulk data and SEC EDGAR company filings say about this entity, with the source and date on every fact. Latest record 2026-08-26.

SEC filer · State registration on file

Inhibikase Therapeutics, Inc.

1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE 19801

EIN

26-3407249

SEC CIK

0001750149

SEC · 2026-08-26

Industry (SIC)

Biological Products, (No Diagnostic Substances) (2836)

SEC · 2026-08-26

State of incorporation

DE

SEC · 2026-08-26

Ticker

IKT

SEC · 2026-08-26

Latest SEC filing

8-K 2026-08-26

SEC · 2026-08-26

Florida registration

Active · Foreign profit corporation

FL Div. of Corporations · 2026-07-10

Florida document number

F26000003746

FL Div. of Corporations · 2026-07-10

Registered in Florida

2026-06-18

FL Div. of Corporations · 2026-07-10

Registered agent

C T CORPORATION SYSTEM

FL Div. of Corporations · 2026-07-10

From Florida Division of Corporations (Sunbiz) bulk data · SEC EDGAR company filings. Latest record 2026-08-26.

What this record is

Public federal filings that carry this EIN, shown as filed. Nothing here is scraped from the IRS and nothing is inferred.

What it is not

Registry status, formation date, and registered agent come from the state where the entity is registered, not from these federal filings.

If something is wrong

A name, address, or classification here is what the source published. To correct the source, file with it; to have this page removed, see corrections and removal.

Look up another business

Free. Federal filings and state registries, stamped with their source and date.